Prosecution Insights
Last updated: April 19, 2026

Cancer Research Technology Limited

11 pending office actions

Portfolio Summary

11
Total Pending OAs
3
Final Rejections
8
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18418855 VECTOR FOR CANCER TREATMENT BATES, KEENAN ALEXANDER 1631 Non-Final OA Jan 22, 2024
18285996 ANTI-CD73 ANTIBODIES OUSPENSKI, ILIA I 1644 Non-Final OA Oct 06, 2023
18470875 ANTI-CD25 ANTIBODY AGENTS LI, RUIXIANG 1674 Non-Final OA Sep 20, 2023
18265063 Aldehyde Dehydrogenase Inhibitors and Their Therapeutic Use HASTINGS, ALISON AZAR 1627 Non-Final OA Jun 02, 2023
18302313 Heterocyclic Compounds as RET Kinase Inhibitors HSU, GRACE CHING 1627 Non-Final OA Apr 18, 2023
17781650 SPATIAL BARCODING LAFAVE, ELIZABETH ROSE 1684 Final Rejection Jun 01, 2022
17770974 PROSTATE CANCER DETECTION METHODS SCHLOOP, ALLISON ELIZABETH 1683 Final Rejection Apr 21, 2022
17721455 VECTOR FOR CANCER TREATMENT BATES, KEENAN ALEXANDER 1631 Final Rejection Apr 15, 2022
17551725 METHODS FOR MODULATION OF AND SENSITIZATION TO SERINE AND GLYCINE LIMITATION RAGHU, GANAPATHIRAM 1652 Non-Final OA Dec 15, 2021
17609691 MEDIATORS OF GENE SILENCING SULLIVAN, STEPHANIE LAUREN 1635 Non-Final OA Nov 08, 2021
16749923 Method for Detecting Tumor DNA in a cfDNA Sample Collected from a Patient that has Previously Undergone Cancer Therapy WOITACH, JOSEPH T 1687 Non-Final OA Jan 22, 2020

Managing Cancer Research Technology Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month